Your browser doesn't support javascript.
loading
Immunological insights: assessing immune parameters in medical professionals exposed to SARS-CoV-2.
Wojas-Krawczyk, Kamila; Krawczyk, Pawel; Blach, Justyna; Kucharczyk, Tomasz; Grenda, Anna; Krzyzanowska, Natalia; Szklener, Katarzyna; Horaczynska-Wojtas, Anna; Wójcik-Superczynska, Magdalena; Chmielewska, Izabela; Milanowski, Janusz.
Afiliação
  • Wojas-Krawczyk K; Department of Pneumonology, Oncology and Allergology Medical University of Lublin, Jaczewskiego 8, Lublin, 20-954, Poland. kamilawojas@wp.pl.
  • Krawczyk P; Department of Pneumonology, Oncology and Allergology Medical University of Lublin, Jaczewskiego 8, Lublin, 20-954, Poland.
  • Blach J; Department of Pneumonology, Oncology and Allergology Medical University of Lublin, Jaczewskiego 8, Lublin, 20-954, Poland.
  • Kucharczyk T; Department of Clinical Immunology Medical University of Lublin, Lublin, Poland.
  • Grenda A; Department of Pneumonology, Oncology and Allergology Medical University of Lublin, Jaczewskiego 8, Lublin, 20-954, Poland.
  • Krzyzanowska N; Department of Pneumonology, Oncology and Allergology Medical University of Lublin, Jaczewskiego 8, Lublin, 20-954, Poland.
  • Szklener K; Department of Pneumonology, Oncology and Allergology Medical University of Lublin, Jaczewskiego 8, Lublin, 20-954, Poland.
  • Horaczynska-Wojtas A; Department of Clinical Oncology and Chemotherapy Medical University of Lublin, Lublin, Poland.
  • Wójcik-Superczynska M; Department of Pediatric Otolaryngology, Phoniatrics and Audiology, University Children's Hospital, Lublin, Poland.
  • Chmielewska I; Department of Pneumonology, Oncology and Allergology Medical University of Lublin, Jaczewskiego 8, Lublin, 20-954, Poland.
  • Milanowski J; Department of Pneumonology, Oncology and Allergology Medical University of Lublin, Jaczewskiego 8, Lublin, 20-954, Poland.
BMC Infect Dis ; 24(1): 865, 2024 Aug 26.
Article em En | MEDLINE | ID: mdl-39187767
ABSTRACT

BACKGROUND:

The immunological background responsible for the severe course of COVID-19 and the immune factors that protect against SARS-CoV-2 infection are still unclear. The aim of this study was to investigate immune system status in persons with high exposure to SARS-CoV-2 infection.

METHODS:

Seventy-one persons employed in the observation and infectious diseases unit were qualified for the study between November 2020 and October 2021. Symptomatic COVID-19 was diagnosed in 35 persons. Anti-SARS-CoV-2 antibodies were also found in 8 persons. Peripheral blood mononuclear cells subpopulations were analyzed by flow cytometry, and the concentrations of cytokines and anti-SARS-CoV-2 antibodies were determined by ELISA.

RESULTS:

The percentages of cytotoxic T lymphocytes (CTLs), CD28+ and T helper (Th) cells with invariant T-cell receptors were significantly higher in persons with symptomatic COVID-19 than in those who did not develop COVID-19' symptoms. Conversely, symptomatic COVID-19 persons had significantly lower percentages of a) CTLs in the late stage of activation (CD8+/CD95+), b) NK cells, c) regulatory-like Th cells (CD4+/CTLA-4+), and d) Th17-like cells (CD4+/CD161+) compared to asymptomatic COVID-19' persons. Additionally, persons with anti-SARS-CoV-2 antibodies had a significantly higher lymphocyte count and IL-6 concentration than persons without these antibodies.

CONCLUSION:

Numerous lymphocyte populations are permanently altered by SARS-CoV-2 infection. High percentages of both populations NK cells-as a part of the non-specific response, and T helper cells' as those regulating the immune response, could protect against the acute COVID-19 symptoms development. Understanding the immune background of COVID-19 may improve the prevention of this disease by identifying people at risk of a severe course of infection. TRIAL REGISTRATION This is a retrospective observational study without a trial registration number.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Ano de publicação: 2024 Tipo de documento: Article